drugset / Trial / NCT00421096

Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical Cancer

NCT00421096 ↗

Phase 2 Terminated 19 enrolled Centre Oscar Lambret
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The scope of the trial is to assess the efficacy of the association gemcitabine-cisplatin + radiotherapy followed by an adjuvant chemotherapy

Timeline

Start
2005-05
Primary completion
2008-04
Completion
2011-12

Outcome

Outcome not reported

Stopped (Enrollment): “Problems of recruitment”

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 40 mg/m2 —
Subject Gemcitabine Small molecule 125 mg/m2 —

Indications